Jazz Pharmaceuticals earnings (net income)
Jazz Pharmaceuticals (JAZZ) earned a net income of −$356.15 M in fiscal year 2025, −164% compared with the year before. Net profit margin: −8.35% of revenue.
Earnings 2025−$356.15 M
Change−164%
World rank#862
Market cap$15.18 B
Net income by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | −$356.15 M | −164% |
| 2024 | $560.12 M | +35.0% |
| 2023 | $414.83 M | — |
| 2022 | −$224.06 M | — |
Data: company filings via Yahoo Finance, updated 2026-11-20. Not investment advice.